Biogen, Inc. (BIIB)
217.15
+1.72
(+0.80%)
USD |
NASDAQ |
Sep 11, 16:00
217.15
0.00 (0.00%)
After-Hours: 20:00
Biogen Price : 217.15 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 216.75 | 219.76 | 214.71 | 217.15 | 1.076M |
| Sep 10, 2026 | 209.92 | 216.70 | 208.93 | 215.43 | 936643.0 |
| Sep 09, 2026 | 210.50 | 213.48 | 209.00 | 210.73 | 694669.0 |
| Sep 08, 2026 | 215.45 | 217.28 | 210.54 | 212.50 | 617829.0 |
| Sep 04, 2026 | 221.15 | 223.82 | 219.82 | 220.83 | 465108.0 |
| Sep 03, 2026 | 225.44 | 225.80 | 221.23 | 224.51 | 550745.0 |
| Sep 02, 2026 | 218.20 | 225.59 | 216.97 | 222.67 | 1.268M |
| Sep 01, 2026 | 218.11 | 219.30 | 213.60 | 216.04 | 785497.0 |
| Aug 31, 2026 | 216.47 | 218.89 | 213.58 | 216.65 | 831004.0 |
| Aug 28, 2026 | 221.17 | 222.00 | 216.78 | 218.50 | 517485.0 |
| Aug 27, 2026 | 219.39 | 222.11 | 217.53 | 221.50 | 497524.0 |
| Aug 26, 2026 | 219.34 | 222.00 | 218.69 | 221.07 | 647334.0 |
| Aug 25, 2026 | 218.93 | 222.85 | 218.00 | 220.77 | 495435.0 |
| Aug 24, 2026 | 216.40 | 218.50 | 213.96 | 218.12 | 649828.0 |
| Aug 21, 2026 | 217.76 | 219.12 | 215.00 | 216.78 | 722348.0 |
| Aug 20, 2026 | 217.98 | 221.29 | 214.16 | 214.35 | 808625.0 |
| Aug 19, 2026 | 215.33 | 222.15 | 215.08 | 221.56 | 886914.0 |
| Aug 18, 2026 | 211.00 | 214.06 | 210.01 | 212.55 | 694009.0 |
| Aug 17, 2026 | 208.36 | 210.49 | 207.62 | 209.15 | 617238.0 |
| Aug 14, 2026 | 210.01 | 210.79 | 208.22 | 209.83 | 554816.0 |
| Aug 13, 2026 | 212.98 | 215.60 | 208.79 | 210.65 | 860095.0 |
| Aug 12, 2026 | 203.52 | 209.22 | 201.00 | 208.87 | 789441.0 |
| Aug 11, 2026 | 206.63 | 207.57 | 203.53 | 203.89 | 936835.0 |
| Aug 10, 2026 | 206.70 | 210.02 | 206.29 | 207.13 | 706425.0 |
| Aug 07, 2026 | 207.38 | 208.31 | 204.16 | 207.94 | 840566.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Ionis Pharmaceuticals, Inc. | 54.21 |
| AbbVie, Inc. | 257.12 |
| Regeneron Pharmaceuticals, Inc. | 781.49 |
| Gilead Sciences, Inc. | 143.72 |
| Vertex Pharmaceuticals, Inc. | 515.44 |
Price Related Metrics
| PE Ratio | 38.46 |
| PS Ratio | 3.320 |
| Price to Book Value | 1.702 |
| Price to Free Cash Flow | 12.88 |
| Earnings Yield | 2.60% |
| Market Cap | 32.07B |
| Operating PE Ratio | 17.03 |
| Normalized PE Ratio | 23.77 |